Loading... Please wait... Loading... Please wait...
ESTIMATED
05/13/2024
05/13/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$1.20 | -$1.20 | -$1.20 |
| Q2 2024 | 1 | -$0.71 | -$0.71 | -$0.71 |
| Q3 2024 | 0 | -$0.63 | -$0.63 | -$0.63 |
| Q4 2024 | 0 | -$0.67 | -$0.67 | -$0.67 |
| Q1 2025 | 0 | -$0.73 | -$0.73 | -$0.73 |
| Q2 2025 | 0 | -$0.79 | -$0.79 | -$0.79 |
Benitec Biopharma Inc. last posted its earnings results on Monday, May 13th, 2024. The company reported $-1.64 earnings per share for the quarter, missing analysts' consensus estimates of $-0.78 by $0.86. The company had revenue of 6,000 for the quarter and had revenue of 75,000 for the year. Benitec Biopharma Inc. has generated $-14 earnings per share over the last year ($-14.12 diluted earnings per share) and currently has a price-to-earnings ratio of -1.05. Benitec Biopharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 19th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/13/2024 | Q3 2024 | -$0.78 | -$1.64 | -0.86 | $6,000 | $6,000 | 02/13/2024 | Q2 2024 | -$0.39 | -$2.64 | -2.25 | $0 | $0 | 11/13/2023 | Q1 2024 | -$0.51 | -$2.76 | -2.25 | $0 | 09/21/2023 | Q4 2023 | -$3.23 | -$2.83 | 0.4 | $7,000 | 05/15/2023 | Q3 2023 | -$0.20 | -$2.71 | -2.51 | $54,000 | 02/13/2023 | Q2 2023 | -$0.11 | -$3.22 | -3.11 | $14,000 | 11/10/2022 | Q1 2023 | -$2.04 | -$8.78 | -6.74 | $472,000 | 09/02/2022 | Q4 2022 | -$4.76 | -$10.54 | -5.78 | $0 | 05/16/2022 | Q3 2022 | -$7.48 | -$6.81 | 0.67 | $48,000 | 02/14/2022 | Q2 2022 | -$13.80 | $25,000 | 11/15/2021 | Q1 2022 | -$10.50 | $0 | 09/20/2021 | Q4 2021 | -$9.64 | $5,000 | $2,000 | 05/12/2021 | Q3 2021 | -$14.00 | $1,000 | 02/09/2021 | Q2 2021 | -$0.75 | -$12.86 | -12.11 | $35,000 | $1,000 | 11/13/2020 | Q1 2021 | -$0.92 | -$41.69 | -40.77 | $65,000 | $55,000 | 09/23/2020 | Q4 2020 | -$0.01 | -$65.78 | -65.77 | $127,230 | $-40,000 | 03/30/2020 | Q3 2020 | -$54.26 | $28,000 | 12/30/2019 | Q2 2020 | -$48.53 | $77,000 | 09/29/2019 | Q1 2020 | -$33.64 | $33,000 | 06/29/2018 | Q4 2018 | -$68.44 | $30,307 |
|---|
A. Benitec Biopharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 19th, 2024 based off last year's report dates.
A. The conference call for Benitec Biopharma Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Benitec Biopharma Inc.'s latest earnings report can be read online.
A. Benitec Biopharma Inc. (NASDAQ:BNTC) has a recorded annual revenue of $75,000.
A. Benitec Biopharma Inc. (NASDAQ:BNTC) has a recorded net income of $75,000. Benitec Biopharma Inc. has generated $-14.12 earnings per share over the last four quarters.
A. Benitec Biopharma Inc. (NASDAQ:BNTC) has a price-to-earnings ratio of -1.05 and price/earnings-to-growth ratio is -0.02.
